Takeaway
SIGMAR1 gene variants are not associated with susceptibility to chronic neuropathic pain but some variants contribute to modulation of somatosensory function.
Why this matters
Insights provided by functional effects of gene variants has potential to improve outcomes for people with neuropathic pain.